Loading...

The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates

CA 19-9 and CEA are the most commonly used biomarkers for diagnosis and management of patients with pancreatic cancer. Since the original compendium by Steinberg in 1990, numerous studies have reported the use of CA 19-9 and, to a lesser extent, CEA in the diagnosis of pancreatic cancer. Here we upd...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Curr Mol Med
Main Authors: Poruk, Katherine E., Gay, David Z., Brown, Kurt, Mulvihill, Jeffrey D., Boucher, Kenneth M., Scaife, Courtney L., Firpo, Matthew A., Mulvihill, Sean J.
Format: Artigo
Sprog:Inglês
Udgivet: 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4419808/
https://ncbi.nlm.nih.gov/pubmed/23331006
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!